University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Building Blocks for COVID-19 Antiviral Drugs Identified in Rapid Study

Building Blocks for COVID-19 Antiviral Drugs Identified in Rapid Study

July 9, 2020

Scientists have identified key chemical building blocks for an eventual antiviral drug against SARS-CoV-2, the virus that causes COVID-19, according to data newly released by members of the UC San Francisco Quantitative Bioscience Institute Coronavirus Research Group (QCRG), based on research conducted with breakneck speed in collaboration ...
New Model of Breast Cancer's Causes Developed by UCSF-led Team

New Model of Breast Cancer's Causes Developed by UCSF-led Team

July 8, 2020

A new model of the causes of breast cancer, created by a team led by researchers at UC San Francisco, Genentech and Stanford University, is designed to capture the complex interrelationships between dozens of primary and secondary breast cancer causes and stimulate further research. Breast ...
Neuro-Oncologist Joins UCSF Brain Tumor Center Team

Neuro-Oncologist Joins UCSF Brain Tumor Center Team

July 8, 2020

This month, neuro-oncologist Jessica Schulte, MD, PhD joins the UCSF Brain Tumor Center team. Dr. Schulte specializes in treatment of adolescent and adult glioma and neurofibromatosis, with a focus on optimizing transitions of care between pediatric and adult medical care.   Dr. Schulte earned her ...
'Scientifically Fearless' Cancer Researcher Zena Werb Dies at 75

'Scientifically Fearless' Cancer Researcher Zena Werb Dies at 75

July 2, 2020

Colleagues are mourning the passing of Zena Werb, PhD, a giant in the field of cancer biology whose four decades of research at UC San Francisco informed the rise of immunotherapy and other modern approaches to cancer treatment. Werb, who was a professor in the ...
What to Expect During Your Next Visit to UCSF Health

What to Expect During Your Next Visit to UCSF Health

June 29, 2020

New processes are in place as a result of COVID-19 and our priority remains the same: your health and safety.
Recombinant Antibody Network Partners with Bristol Myers Squibb to Develop Novel Therapies

Recombinant Antibody Network Partners with Bristol Myers Squibb to Develop Novel Therapies

June 18, 2020

The Recombinant Antibody Network (RAN), a consortium comprising research groups from UC San Francisco, the University of Chicago, and the University of Toronto, has entered into a second research collaboration with Celgene that aims to create and develop high-performance recombinant antibodies against diverse targets in ...